Concepedia

Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM

James M. Markert, Peter Liechty, Wenquan Wang, Shanna Gaston, Eunice Braz, Matthias Karrasch, Burt Nabors, Michael Anne Markiewicz, Alfred D. Lakeman, Cheryl A. Palmer,

Molecular Therapy · 2008 · 404 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp, Warren Mason, Martin J. van den Bent et al. · New England Journal of Medicine · 2005 · 21.6K citations · Full text

, , +12

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text

, , +17

Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery

Michael Walker, Sylvan B. Green, David P. Byar et al. · New England Journal of Medicine · 1980 · 1.6K citations

, , +9

Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant

Robert L. Martuza, Amy Malick, James M. Markert et al. · Science · 1991 · 1K citations

, , +14

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

James M. Markert, Michael D. Medlock, Samuel D. Rabkin et al. · Gene Therapy · 2000 · 978 citations

, , +9